New pancreatic cancer data are now available through the Genomic Data Commons (GDC), Proteomic Data Commons (PDC), and The Cancer Imaging Archive (TCIA). In this data release, researchers can access cases from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) pancreatic ductal adenocarcinoma (PDAC) discovery study. PDAC accounts for more than 90% of pancreatic cancer cases and has an average 5-year survival rate of less than 10%. CPTAC investigators have used proteogenomic methods to learn more about this devastating cancer, and now all the data is freely available (under publication embargo) to the public.

Explore the genomic data through the GDC: 

• Whole Genome (WGS) 
• Whole Exome (WES) 
• RNA-Sequencing (RNA-seq) 
• miRNA-Sequencing (miRNA-Seq) 
• Targeted Sequencing Data

Explore the proteomic data through the PDC: 

• Proteomic 
• Phosphoproteomic 
• Glycoproteomic

Explore the clinical imaging data through TCIA: 

• Histology 
• Radiology images 

Additionally, genomic data from the Count Me In’s Metastatic Prostate Cancer project and NCI’s Human Cancer Models Initiative have been added to this release. Detailed information on what is included in the release can be found in the GDC Data Release notes and PDC Data Set Release notes.

As components of the Cancer Research Data Commons, the GDC and PDC allow researchers to explore the data directly through each data portal or access the data via one of NCI’s Cloud Resources.